Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs Vanguard Ultra Short Bond ETF (VUSB) Price & Performance

Axogen IncTrade
Vanguard Ultra Short Bond ETFTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Vanguard Ultra Short Bond ETF — how do they compare? Axogen Inc trades at $48.35 (market cap $2.61B), while Vanguard Ultra Short Bond ETF trades at $49.67. The key difference: Axogen Inc is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.

AXGNVUSB
Market Cap
$2.61B
Sector
TechnologyLeveraged / Inverse
52-Week High
$48.48$50.03
52-Week Low
$14.16$49.60
Enterprise Value
$2.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN is trading at $46.43, up 4.69% today, with strong technical momentum and bullish moving average signals. The company reported Q2 2026 revenue growth of 23.1% to $69.7 million and raised full-year guidance to at least $279 million. Despite recent earnings misses, analyst sentiment remains overwhelmingly positive with 84% buy ratings and a $54.33 price target.

The stock presents growth potential driven by expanding nerve care platform adoption and reimbursement improvements, but faces risks from persistent net losses (-$15.7M in 2025) and high valuation multiples (P/S 9.5). Near-term performance hinges on Q3 earnings delivery and continued commercial execution amid competitive pressures.

Vanguard Ultra Short Bond ETF

VUSB trades at $49.66, up 0.04% on the day, with a bearish technical signal driven by moving averages and ADX readings. Recent dividends include $0.18 paid on July 6, 2026, and $0.17 scheduled for August 5, 2026. Financial ratios such as P/E and ROE are unavailable in the current data, limiting fundamental assessment.

The outlook is cautious due to bearish technical indicators and incomplete financial data. Risks include interest rate sensitivity, as highlighted by recent Fed commentary, and reliance on short-term bond performance. Investors should await updated financial disclosures for a clearer fundamental picture.

Returns comparison

Trailing returns across standard periods

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About Vanguard Ultra Short Bond ETF

VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.

Read more on VUSB